SCHEMBL32665176

SCHEMBL32665176

O=C(c1ccc(OS(=O)(=O)F)c(F)c1)N1CCC2(CC1)CC(N1C(=O)C=CC1=O)C2

nearest known ligand 0.37

Predicted protein targets (top 18)

geneUniProtsupporting neighboursconfidence
STS P08842 1/20 0.36
MAPK1 P28482 1/20 0.36
KMT2A Q03164 3/20 0.35
MEN1 O00255 2/20 0.35
GPR119 Q8TDV5 1/20 0.35
CYP3A4 P08684 3/20 0.35
HSD17B10 Q99714 2/20 0.35
ALDH1A1 P00352 2/20 0.35
CYP2D6 P10635 2/20 0.35
KDM4E B2RXH2 1/20 0.35
HPGD P15428 1/20 0.35
TSHR P16473 1/20 0.35
HTR1A P08908 3/20 0.35
USP2 O75604 2/20 0.34
CYP1A2 P05177 2/20 0.34
GPR183 P32249 1/20 0.34
HSD11B1 P28845 1/20 0.34
HIF1A Q16665 1/20 0.34

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL32665031 0.92 HTR1A (0.38) MAPK1KMT2AMEN1CYP3A4HSD17B10
SCHEMBL32665523 0.85 CYP2D6 (0.41) MAPK1CYP3A4HSD17B10ALDH1A1CYP2D6
SCHEMBL32665186 0.83 MAPK1 (0.41) MAPK1KMT2AMEN1CYP3A4HSD17B10
SCHEMBL32665089 0.79 DOCK5 (0.35) MAPK1GPR119ALDH1A1GPR183
SCHEMBL32665432 0.73 NPSR1 (0.36) KMT2AMEN1ALDH1A1GPR183
SCHEMBL32665268 0.69 CYP2C9 (0.33) MAPK1CYP3A4HSD17B10ALDH1A1CYP2D6
SCHEMBL32665454 0.69 FFAR4 (0.38) MAPK1CYP3A4HSD17B10ALDH1A1CYP2D6
SCHEMBL32665034 0.69 L3MBTL3 (0.46) KMT2AMEN1ALDH1A1KDM4EHSD11B1
SCHEMBL2762425 0.66 MAPK1 (0.62) MAPK1KMT2AMEN1CYP3A4ALDH1A1
SCHEMBL32665353 0.65 RAB9A (0.62) STSMAPK1KMT2AMEN1ALDH1A1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20260021192-A1 PROTEINS HAVING A COVALENT WARHEAD TOPAZ THERAPEUTICS INC (US) 2026-01-22 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20260021192-A1 PROTEINS HAVING A COVALENT WARHEAD RIOX2, ORC3, DCLRE1A STS 3493/4885MAPK1 4524/4885KMT2A 4014/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.